Plans

Mounjaro

Take once weekly

Potential weight loss of up to 22%*.

Reduce cravings and feelings of hunger

Real Results

Weight 124.7 kg -27kg

Exclusive Summer Offer - £189.00 £119.00

Exclusive Summer Offer: Promo Code: SAVE70 at
checkout and get £70.00 off your first order!

Proven Weight Loss

Weight loss plans for those wanting long-term results.

Clinically proven weight loss of up to 22%

Scientifically backed weight loss programme

UK Licensed – Professional clinical care

Exclusive Summer Offer - £189.00 £119.00

Weight Loss of Up To 22% in less than 18 months*

Simple, effective and proven. This could be the last weight loss programme you will ever need

Proven Treatment

Clinical trials* have seen clients reduce body weight by up to 22% when combined a balanced diet and exercise.

Reduce Cravings

Prescribed, weight loss medication that reduces cravings and helps control your appetite.

Professional-Clinical Care

Dedicated team of clinicians on hand to help you throughout your plan, adjust dosages and manage potential side effects.

*Jastrebroff et al. Tirzepatide Once Weekly for the Treatment of Obesity involving 2,539 adults. NEJM (2022)

Regulated by the GPhC

Discreet packaging

Rated excellent on Trust Pilot

Your Weight Loss Journey Starts Here

The results you could achieve from your Happen plan:

Start Today

Easy online consultation

Complete the online consultation. If eligible, our clinicians can prescribe your weight loss medication. All approved prescriptions are sent out via next day delivery, free of charge.

First 6 Months

Healthy weight loss

Taking the medication once weekly, see a potential weight loss of up to 10%. Forming new healthy lifestyle and dietary habits, increasing the likelihood of long-term results.

6 - 12 Months

Long-term results

Gradual increased dosages, healthier lifestyle habits and ongoing support can set you on your way to achieving long-term, sustainable weight loss.

Your Choice of Weight Loss Treatments

Prescribed weight loss medication to help lose weight, set healthy lifestyle habits and achieve long-term results:

Mounjaro

Clinically proven weight loss medication that regulates your appetite.

Starting From: £189.00 £119.00

Take once weekly

Potential weight loss of up to
22%*.

Reduce cravings and feelings of hunger

Client portal + progress tracking tools

Frequently Asked Questions

Ask away, we’ve got you covered.


Our products are licensed and approved by the MHRA for weight loss use in the UK for weight loss.


A weight loss pen refers to a device used to administer treatments that are designed to aid in weight loss, commonly GLP-1 receptor agonists. These mimic a natural hormone in the body called GLP-1, a natural hormone in the body that helps regulate blood sugar levels, insulin secretion, and feelings of satiety.


As with any new treatment, weight loss pens come with several potential side effects. Individual responses to treatments can vary, and not everyone will experience the same side effects.

We strongly recommend reviewing the landing page for each of Happen’s products to understand specific side effects associated with different types of treatment.


The time it takes for individuals to see results can differ among individuals. Generally, people may begin to see some changes within a few weeks to a few months, but it’s important to note that individual responses to weight loss treatments can vary greatly.


The products on our site are prescribed on a case-by-case basis, based on individual health conditions and needs, and therefore are not suitable for everyone. Each product’s use requires careful consideration by a healthcare professional.


No, we only ship within the UK

Can’t find what you’re looking for? click here

As seen in

happen

Legal

Pharmacy: The Family Health Pharmacy

Superintendent Pharmacist: Jamila Maqsumi Mohamed

GPhC Registration: 2231903

ICO Number: ZB700575

Copyright 2024 Happen. All rights reserved.

Clinical trials:
*Jastrebroff et al. Tirzepatide Once Weekly for the Treatment of Obesity NEJM (2022)
*Wilding et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity NEJM (2021)